Nozomu Koyanagi

Discovery of Novel Antitumor Sulfonamides Targeting G1 Phase of the Cell Cycle

Takashi Owa, Hiroshi Yoshino, Tatsuo Okauchi et al. · Journal of Medicinal Chemistry · 1999 · 323 citations

Tumor Biology, Medicinal Chemistry, Drug Targeting +15

Novel sulfonamides as potential, systemically active antitumor agents

Hiroshi Yoshino, Norihiro Ueda, Jun Niijima et al. · Journal of Medicinal Chemistry · 1992 · 233 citations

Chemoprevention Strategy, Altmetric Attention Score, Pharmacotherapy +20

Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.

Kumiko Yoshimatsu, Atsumi Yamaguchi, Hiroshi Yoshino et al. · PubMed · 1997 · 181 citations

Cell Death, Colchicine Site, Cytoskeleton +17

E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo

Yoichi Ozawa, Naoko Hata Sugi, Takeshi Nagasu et al. · European Journal of Cancer · 2001 · 132 citations

Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Science +10

Effect of vitamin K2 on the recurrence of hepatocellular carcinoma

Haruhiko Yoshida, Yasushi Shiratori, Masatoshi Kudo et al. · Hepatology · 2011 · 126 citations